| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 230.10M | 247.30M | 316.40M | 290.40M | 240.30M |
| Gross Profit | 96.30M | 97.00M | 131.30M | 120.60M | 108.30M |
| EBITDA | 19.50M | 24.00M | 32.80M | -7.10M | 42.90M |
| Net Income | -11.40M | -9.60M | -9.20M | -20.00M | 22.60M |
Balance Sheet | |||||
| Total Assets | 423.70M | 416.20M | 446.30M | 481.70M | 272.20M |
| Cash, Cash Equivalents and Short-Term Investments | 33.80M | 13.90M | 12.00M | 22.30M | 9.00M |
| Total Debt | 128.40M | 163.20M | 180.80M | 225.70M | 41.70M |
| Total Liabilities | 251.10M | 270.30M | 291.00M | 342.20M | 99.80M |
| Stockholders Equity | 172.10M | 145.30M | 154.60M | 138.60M | 171.50M |
Cash Flow | |||||
| Free Cash Flow | 32.40M | 35.30M | 17.40M | -26.90M | 13.60M |
| Operating Cash Flow | 38.00M | 55.40M | 57.50M | -7.50M | 35.50M |
| Investing Cash Flow | -26.90M | -20.00M | -39.90M | -89.30M | -21.90M |
| Financing Cash Flow | 10.20M | -33.50M | -27.00M | 103.30M | -18.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £259.85M | 3.87 | 15.22% | 3.92% | 18.90% | -20.79% | |
75 Outperform | £818.19M | 7.96 | 15.54% | 1.11% | 8.20% | 25.85% | |
64 Neutral | £272.64M | 8.85 | 13.87% | 2.58% | -0.33% | 4.58% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £111.79M | -3.44 | 15.77% | ― | -5.73% | ― | |
56 Neutral | £348.46M | -21.41 | -6.50% | ― | -18.43% | 24.86% | |
52 Neutral | £112.51M | -3.53 | -76.88% | ― | 732.03% | 12.60% |